Newbury Pre Diabetes Project A real-world implementation of QDiabetes - - PowerPoint PPT Presentation

newbury pre diabetes project
SMART_READER_LITE
LIVE PREVIEW

Newbury Pre Diabetes Project A real-world implementation of QDiabetes - - PowerPoint PPT Presentation

Newbury and District CCG Newbury Pre Diabetes Project A real-world implementation of QDiabetes in a CCG Area Tim Walter Aims of the PreDM Project Raise awareness generally Lifestyle intervention for those at risk Early identification


slide-1
SLIDE 1

Newbury Pre Diabetes Project

A real-world implementation of QDiabetes in a CCG Area

Tim Walter Newbury and District CCG

slide-2
SLIDE 2

 Raise awareness generally  Lifestyle intervention for those at risk  Early identification of those at risk of, or already with DM2 without a diagnosis

Aims of the PreDM Project

slide-3
SLIDE 3

 My Journey  Newbury Pre-Diabetes Project

 Phase 1 Lifestyle Intervention - Surgeries  Phase 2 County Show experience  Phase 3 Targeted screening  As an example to copy/change as you wish

 Resources www.predm.co.uk

What to expect from today

slide-4
SLIDE 4

Trends at Falkland Surgery

 2000 Type 1 DM = 44 Type 2 DM = 150 (194)  2005 Type 1 DM = 56 Type 2 DM = 250 (306)  2008 Type 1 DM = 66 Type 2 DM = 369 (435)  2012 Type 1 DM = 73 Type 2 DM = 399 (472)  12/11/2013 Total 498  The massive increase in DM is predominantly in the Type 2 group  About 3.5% of population

slide-5
SLIDE 5

Summary of historic care

 1990’s – minimise impact (Symptoms and meds)  2000’s – move to targets and “maximize dose” and identify missed diagnosis  2010’s – earlier diagnosis (seeking borderline results)

  • f pts with IGT, single Random BS readings etc
slide-6
SLIDE 6
slide-7
SLIDE 7

 Inaugural joint 2012-13 winners

 Funded by QResearch ( in a joint partnership between Emis, Emis NUG and University of Nottingham)

 Prof. Aziz Sheikh of Primary Care Research & Development at the University of Edinburgh – Smoking Cessation  Myself – Pre-Diabetes Project

 Plus John Robson and Kambiz Boomla

QInnovation

slide-8
SLIDE 8

Nice Guidance

Recent National Institute for Health and Clinical Excellence (NICE) guidance has recommended:

  • Identifying people at risk of developing type 2 diabetes, using a

validated risk assessment score and a blood test (fasting blood glucose or HbA1c) to confirm high risk.

  • Providing those at high risk with an intensive lifestyle-change

programme to prevent or delay the onset of type 2 diabetes.

slide-9
SLIDE 9

 Recommendation 3 Developing a local strategy  Recommendation 6 Conveying messages to the local population  Recommendation 8 Promoting a healthy diet: local action  Recommendation 10 Promoting physical activity: local action

Nice PH35

Preventing type 2 diabetes: population and community-level interventions

slide-10
SLIDE 10

 reduce their weight by more than 5%  keep their fat intake below 30% of energy intake  keep their saturated-fat intake below 10% of energy intake  eat 15 g/1000 kcal of fibre or more  are physically active for at least 4 hours per week.

Finnish Diabetes Prevention Study

slide-11
SLIDE 11

 QDiabetes Tool  Concept of Pre-Diabetes  Early intervention reduces risk by up to 60% (Finnish Study and DPP in USA)  Lifestyle interventions (E4H) work in the short term  Project looks to combine these to assess practical issues and costs

Components of the project

slide-12
SLIDE 12

 113,000 - mixed clinical system CCG  Surgery Process, 1st cohort EmisWEB

 Instructions to practices to run the bulk QDiabetes module  Identify patients with > 30% 10yr risk  Invitation to have bloods and join E4H Group  Currently ending 2nd Cohort phase, LV and INPS  Starting SystmOne and last EmisWEB practice

Newbury PreDM Project

slide-13
SLIDE 13

 50 patients invited per practice (8 surgeries) (30-80% risk calculations)  400 in first 2 cohorts  18% uptake  Of those having bloods 14% at diagnostic levels, more with marginal results  E4H – Average 3kg Weight loss, = 110Kg total in 1st cohort  Up to 15Kg loss  1kg =16% risk reduction in DM

Surgery Phase 1st and 2nd Cohort Results

slide-14
SLIDE 14

 Admin charge 150  E4H staff cost 400  Accommodation 400  Total cost therefore 1000 per practice  Approx benefit – 1DM, average 3kg weight loss per participant, raising profile etc

Surgery Phase - Costs per practice

slide-15
SLIDE 15

 60,000 attendees  21-22nd September  2 clinicians doing QDiabetes Screening  2 PH Nurses doing HbA1c for those with high scores  3 E4H staff giving advice, BCA and enrolling to E4H Sessions

Newbury Show

slide-16
SLIDE 16

Newbury Show Pre- Diabetes Stand

During a quiet spell!

Newbury Show Stand

slide-17
SLIDE 17
slide-18
SLIDE 18

 Potential Audience of 60,000  310 Screened via QDiabetes on iPads  111 targeted HbA1c tests done (Approx 1/3rd)  80 Body Fat/Composition Measurements  30 people signed up for E4H classes  5 New diabetics (up to HbA1c = 64) plus 5 HbA1c 42-47  NB Health Promotion vs Detection

Newbury Show - Results

slide-19
SLIDE 19

Is it financially worthwhile

Breast screening

2 million women 15000 diagnoses 96 million pounds 50 pounds per screen 6000 pounds per diagnosis

slide-20
SLIDE 20

Is it financially worthwhile

Cervical cancer

5 million invites 3.5 million tests 200,000 abnormals 4000 cancers prevented 175 million pounds About 1000 pounds per abnormal, and about 40,000 pounds per cancer prevented

slide-21
SLIDE 21

Is it financially worthwhile ???

Diabetes – Newbury Show

60,000 attendees 310 screened with QDiabetes 111 HbA1c tests 5 New Diabetics Cost per diagnosis 1000 pounds

slide-22
SLIDE 22

 Trial this weekend at Falkland Surgery  266 pts with Risk > 15% (without recent bloods done)  Half invited to POC Saturday Drop-in Clinic  Half Posted letter and blood test form  IF numbers are maintained we expect 5% diagnostic rate, and 5% borderline rate

Phase 3 - Identification

slide-23
SLIDE 23

 30% predictive risk seems to = 14% current DM  15% predictive risk seems to = 5% current DM  Letter stating numerical risk seems to trigger response in some of them  E4H making significant impact  It is possible to screen surgery populations  It is possible to organize public event

Overall results

slide-24
SLIDE 24

 Raise awareness generally

 Radio Berkshire  Newbury Weekly News and Chronicle  Health Service Journal  Pulse  Newbury Show

 60,000 visitors

Aims of the PreDM Project

slide-25
SLIDE 25

 Lifestyle intervention for those at risk

 E4H invitations

 550 patients  100 attendees  Potentially 1/3 tonne weight loss!

Aims of the PreDM Project

slide-26
SLIDE 26

 Early identification of those at risk of, or already with DM2 without a diagnosis

 Phase 1 - Potentially 14 New DM  Phase 2 – 5 New DM  Phase 3 -Invitation for screening  One practice 266 patients  11 practices 1500 patients?

 Anticipated pickup rate of 5% in those responding  Possibly 30-70 new diagnoses

Aims of the PreDM Project

slide-27
SLIDE 27

 Public Health

 Indicated they wish to repeat the Lifestyle intervention with E4H across NDCCG

 NDCCG

 Anticipate asking them to fund the detection arm of the project across the whole CCG population if Falkland Trial successful

The Future

slide-28
SLIDE 28

 Do you know how many patients have RBS > 11 or FBS > 7 or HbA1c > 47  Have all those patients with RBS > 7 had a recent follow up blood test  Have you reviewed the patients with IGT/IFG recently to see if they have been rechecked (20-50% 10yr conversion)

Challenges for you -Practices

slide-29
SLIDE 29

 EmisWEB

 Activate popups that notify you of possible and probable DM  Consider installing QDiabetes Popup

Consider - Practices

slide-30
SLIDE 30

 Incentivize the Practices to do the above  Consider how you are responding to NICE Guidance

 Identification of those with DM (offer screening for those at 15% risk)  Prevention of DM (targeted E4H lifestyle interventions)

 Apply pressure to Software suppliers to integrate risk scoring software in INPS and SystmOne

Challenges - Commissioners

slide-31
SLIDE 31

www.predm.co.uk Thank-you Tim Walter

Resources

slide-32
SLIDE 32
slide-33
SLIDE 33
slide-34
SLIDE 34
slide-35
SLIDE 35

 No proof of results (not enough power)  No long term data re weight loss etc.  Cost effectiveness

 Need to define your terms!

 Rural Berkshire 3.5% prevalence

 Actual 5% ? (wide confidence margins)

Caveats

slide-36
SLIDE 36

 QInnovation – go for it  Surgery actions – resources online  CCG actions – “template” online  Not trying to produce research evidence of effectiveness but template for whether it is possible  Any Questions  www.predm.co.uk

Conclusions